Trump’s 15% tariff on medicines will harm patients, say EU drugmakers
Trade group says levy will reduce access, disrupt supply chains and cut R&DWegovy maker Novo Nordisk’s shares plunge on sales forecastThe European pharmaceutical industry has condemned the US move to put 15% tariffs on medicines imported from the E…